A Study of the Efficacy and Safety of Re-treatments With Rituximab in Patients With Active Rheumatoid Arthritis Who Have Had an Inadequate Response to Anti-tnfa Therapies
Clinical trial NCT02097745 · COMPLETED
Trial details
- NCT number
- NCT02097745
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-06-01
- Primary completion
- 2013-06-01
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.